Sobi receives FDA approval to manufacture Kineret® with partner Boehringer Ingelheim
Boehringer Ingelheim pioneers biopharmaceuticals move to China
Sobi receives EMA approval to manufacture Kineret® drug substance with partner Boehringer Ingelheim
Boehringer Ingelheim and Apexigen sign manufacturing agreement for process development and early stage clinical supply
Boehringer Ingelheim and BaroFold Announce Strategic Agreement on PreEMT™ High Pressure Protein Refolding Technology
Do you have any inquiries, questions or comments? Please get in touch with us.